NASD · Healthcare · Medical Devices · USA
QuidelOrtho Corp is a small cap company (market value between $300 million and $2 billion) in the Medical Devices industry.
QuidelOrtho Corp provides diagnostic testing solutions across five business units: Labs, Point of Care, Molecular Diagnostics, Transfusion Medicine and specialized products. The company reaches clinicians and patients through direct sales and distributor networks globally, with production sites in the U.S., U.K. and China. Its customers include hospitals, clinical laboratories, physician offices, blood banks, pharmacies and retail settings.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the QuidelOrtho Corp stock.
Undervalued: intrinsic value $38.62 per share, market price $14.21, margin of safety 63.2% (as of 2026-10-20).
Its through-the-cycle earnings (15.2% median margin), capitalised at 6.4% with no growth, values the shares at $38.62; the price of $14.21 is 63% below that value.
17 more funds hold it; the full list is part of the paid plan.
All 142 Medical Devices stocks
QDEL is undervalued (as of the 2026-10-20 close). Its through-the-cycle earnings (15.2% median margin), capitalised at 6.4% with no growth, values the shares at $38.62; the price of $14.21 is 63% below that value.
$38.62 per share (as of the 2026-10-20 close), against a market price of $14.21. That is a margin of safety of 63.2%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.